Market Cap 2.53B
Revenue (ttm) 241.62M
Net Income (ttm) -25.03M
EPS (ttm) N/A
PE Ratio 84.49
Forward PE 55.47
Profit Margin -10.36%
Debt to Equity Ratio 0.28
Volume 1,194,500
Avg Vol 1,946,178
Day's Range N/A - N/A
Shares Out 33.56M
Stochastic %K 40%
Beta 2.12
Analysts Strong Sell
Price Target $102.00

Latest News on TMDX

TransMedics to Present at Upcoming March Investor Conferences

Feb 18, 2025, 4:05 PM EST - 4 days ago

TransMedics to Present at Upcoming March Investor Conferences